2025 annual financial data
Biodexa Pharmaceuticals 2025 Financial results
Direct answer
Revenue was 0 GBP.
Operating income was -8,268,734 GBP and net income was -6,244,097 GBP.
Operating cash flow was -5,394,140 GBP.
Get free Biodexa Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 GBP
- Operating income
- -8,268,734 GBP
- Net income
- -6,244,097 GBP
- Operating cash flow
- -5,394,140 GBP
Explore related company data
View all 2025 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Biodexa Pharmaceuticals financial years